Myeloid cell Nuclear Differentiation Antigen (MNDA) is an interferon-inducible regulator of myelopoiesis. Potential role in the myeloid-biased aging process
Ageing Res Rev. 2026 Mar 24:103112. doi: 10.1016/j.arr.2026.103112. Online ahead of print. ABSTRACT Aging is a myeloid-biased process, i.e., the differentiation of myeloid cells increases, while the lymphoid lineage declines. Cellular senescence increases the secretion of inflammatory mediators which skew hematopoiesis toward myeloid cell generation. Myeloid cell nuclear differentiation antigen (MNDA) is a type-1 interferon […]
Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia-reperfusion lung injury and pneumonia
Bioact Mater. 2026 Mar 16;62:319-341. doi: 10.1016/j.bioactmat.2026.03.024. eCollection 2026 Aug. ABSTRACT Lung ischemia-reperfusion injury and severe pneumonia represent major clinical challenges with high mortality rates and a lack of effective targeted therapies after lung transplant. Their pathogenesis involves multiple factors, including immune dysregulation, oxidative stress, and mitochondrial dysfunction, which limit the efficacy of single-target treatment […]
An Engineered Triple-Functional Nanoplatform for Effective Sepsis Therapy via Macrophage-Targeted Polo-like Kinase 1 Inhibition
ACS Nano. 2026 Mar 23. doi: 10.1021/acsnano.5c20947. Online ahead of print. ABSTRACT Sepsis accounts for 20% of global mortality, largely driven by dysregulated hyperactivation of macrophages that disrupts immune homeostasis. Current anti-inflammatory strategies often compromise pathogen clearance and exacerbate immunosuppression. Precisely targeting hyperactivated macrophages while preserving antimicrobial function represents a promising therapeutic approach. Through high-throughput […]
Spatial transcriptomic profiling identifies lacrimal-gland-epithelial cell-driven mechanisms underlying autoimmunity in Sjögren’s disease
Front Immunol. 2026 Mar 5;17:1759347. doi: 10.3389/fimmu.2026.1759347. eCollection 2026. ABSTRACT INTRODUCTION: Sjögren’s disease (SjD) is the second most prevalent rheumatic disease and is characterized by autoimmune pathology targeting the tear-producing lacrimal glands, leading to chronic ocular surface disease. Despite important advances, lacrimal gland pathology in SjD remains incompletely understood, limiting both diagnosis and treatment. METHODS: […]
NRF2 Deficiency Disrupts Mitochondrial Homeostasis via NDUFS7 in Trabecular Meshwork
Research (Wash D C). 2026 Mar 20;9:1203. doi: 10.34133/research.1203. eCollection 2026. ABSTRACT The trabecular meshwork (TM) plays a pivotal role in maintaining intraocular pressure (IOP) by regulating aqueous humor outflow. Nuclear factor erythroid 2-related factor 2 (NRF2) was identified as a key transcriptional controller of TM redox balance and mitochondrial function. Transcriptomic profiling of tert-butyl […]
Diabetes associated pericyte metabolic signatures and pathogenesis of diabetic retinopathy
Front Endocrinol (Lausanne). 2026 Mar 6;17:1771836. doi: 10.3389/fendo.2026.1771836. eCollection 2026. ABSTRACT Pericytes are metabolically active perivascular supporting cells. They are essential for establishing and maintaining the inner blood retinal barrier and retinal neurovascular homeostasis. In diabetic retinopathy, the chronic hyperglycemic environment adversely affects pericyte functions including their glucose flux and metabolism. The early alterations in […]
Nitazoxanide reduced inflammatory markers and mitochondrial changes in human retinal endothelial cells grown in high glucose
Mol Vis. 2025 Oct 3;31:351-357. eCollection 2025. ABSTRACT PURPOSE: To determine whether nitazoxanide (NZT) can increase mitochondrial nuclear retrograde regulator 1 (MNRR1) in retinal endothelial cells (RECs) grown in normal or high glucose and thereby reduce inflammation. METHODS: We used control and diabetic human retinal protein samples, control and diabetic mouse retinal samples, and RECs […]
Novel drug development for geographic atrophy
Asia Pac J Ophthalmol (Phila). 2026 Mar 19:100305. doi: 10.1016/j.apjo.2026.100305. Online ahead of print. ABSTRACT Geographic atrophy (GA), the advanced stage of dry age-related macular degeneration, has transitioned from an untreatable condition to a field of active therapeutic development. This review outlines the key molecular pathways driving GA progression, including complement system dysregulation, oxidative stress, […]
A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease
Mol Genet Genomics. 2026 Mar 21;301(1):78. doi: 10.1007/s00438-025-02321-y. ABSTRACT Inherited ocular fundus diseases are the most common causes of blindness with high heterogeneity. We established a tiered strategy for the molecular diagnosis of unexplained vision loss patients. Patients were screened with ophthalmological examinations followed by a tiered genetic diagnosis, including mitochondrial genome sequencing, multigene panel […]
Modulating GRP75 to restore calcium homeostasis: a novel neuroprotective strategy of CRSE6# in Parkinson’s disease models
J Adv Res. 2026 Mar 18:S2090-1232(26)00255-9. doi: 10.1016/j.jare.2026.03.034. Online ahead of print. ABSTRACT INTRODUCTION: Parkinson’s disease (PD) is characterized by dopaminergic neuron loss and α-synuclein (α-syn) aggregation, with no available disease-modifying treatments. Endoplasmic reticulum (ER) stress and consequent mitochondrial calcium overload via the IP3R-GRP75-VDAC1 axis are key pathogenic mechanisms. OBJECTIVES: This study aimed to evaluate […]